AUG 20, 2018 06:45 AM PDT

Using Population Genetics to Predict Disease Risk

WRITTEN BY: Carmen Leitch

Science has identified many diseases that can be traced back to an error in a gene, sometimes only a tiny one. But the cause of many deadly diseases is far more complex, and the risk of developing those diseases can be influenced by small changes in many different genes. Now researchers are beginning to understand how to formulate what we know about those small genetic changes into a more significant message about who is at high risk of getting diseases like type 2 diabetes, coronary artery disease, breast cancer, and other conditions.

Image credit: Maxpixel

This work, reported in Nature Genetics by a team of scientists at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School has created a new kind of genetic test that compiles information from millions of different places throughout the human genome to characterize a person’s risk for five diseases. This test may show who is likely to get a disease before they get symptoms, which can help prevent some of these illnesses from happening in the first place.

“We’ve known for [a] long time that there are people out there at high risk for disease based just on their overall genetic variation,” explained senior author Sekar Kathiresan, an institute member and director of the Cardiovascular Disease Initiative at the Broad Institute, as well as director of the Center for Genomic Medicine at MGH and a professor of medicine at Harvard Medical School. “Now, we’re able to measure that risk using genomic data in a meaningful way. From a public health perspective, we need to identify these higher-risk segments of the population so we can provide appropriate care.”

Data from whole-genome sequencing was used with algorithms that assigned risk scores to genetic variations that have been associated with the development of inflammatory bowel disease, coronary artery disease, type 2 diabetes, atrial fibrillation, or breast cancer. That data creates a polygenic risk score, which can predict a person’s risk of getting one of those diseases (and is described in the video). The team found that millions of people seem to be at heightened risk for some of these and other illnesses, suggesting that this effort should be expanded. These scores were tested and validated.

In people with heightened risk, there was no other indication that the disease could strike. “These individuals, who are at several times the normal risk for having a heart attack just because of the additive effects of many variations, are mostly flying under the radar,” explained co-first author Amit V. Khera, a cardiologist at MGH. “If they came into my clinical practice, I wouldn’t be able to pick them out as high risk with our standard metrics. There’s a real need to identify these cases so we can target screening and treatments more effectively, and this approach gives us a potential way forward.”

For coronary artery disease, it appears that about eight percent of people in the UK biobank are at heightened risk for getting the illness compared to others. For breast cancer, one and a half percent of people are at triple the risk for the disease compared to the average individual.

“Ultimately, this is a new type of genetic risk factor,” said Kathiresan. “We envision polygenic risk scores as a way to identify people at high or low risk for a disease, perhaps as early as birth, and then use that information to target interventions — either lifestyle modifications or treatments — to prevent disease. For heart attack, I foresee that each patient will have the opportunity to know his or her polygenic risk number in the near future, similar to way they can know their cholesterol number right now.”

It will also be important to screen many ethnicities for variants that link to disease risk, to be sure that this health information will be used equitably.

Hear more about how these scores might be used in the clinic from the video.

Sources: AAAS/Eurekalert! via Broad Institute, Nature Genetics

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 12, 2019
Genetics & Genomics
NOV 12, 2019
Why are More Boys Born than Girls?
On average, there are 105 boys born for every 100 girls. Is it purely a genetic tendency or are there environmental factors at play too?  Back in 2008...
NOV 12, 2019
Drug Discovery & Development
NOV 12, 2019
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
NOV 12, 2019
Genetics & Genomics
NOV 12, 2019
How Epigenetics Could Cure Addiction
Addictive behavior is characterized by relapse- being triggered by environmental factors to re-engage in harmful behavior from drug abuse to self harm. One...
NOV 12, 2019
Drug Discovery & Development
NOV 12, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
NOV 12, 2019
Microbiology
NOV 12, 2019
A Bacterial Pathogen Can Steal Huge Chunks of DNA From Other Microbes
Microorganisms are everywhere, and they are often engaged in a fight for resources with other microbes....
NOV 12, 2019
Genetics & Genomics
NOV 12, 2019
Genetic Link to SIDS is Revealed
Around 3,500 American babies die of sudden unexpected infant death every year....
Loading Comments...